Literature DB >> 17846731

[The German Network for Systemic Scleroderma].

P Moinzadeh1, A Fehr, B Damm, T Krieg, N Hunzelmann.   

Abstract

Systemic scleroderma (SSc) is a rare, heterogenous, multisystem disease affecting different organ systems and therefore requires interdisciplinary management and patient care. The German Network for Systemic Scleroderma, funded by the country's Federal Ministry of Education and Research, was established 3 years ago and comprises dermatologists, rheumatologists, pulmonologists, and nephrologists from more than 40 medical centers. The registry contains data of more than 1800 patients. Analysis of the continually growing body of data will form the basis for the development of standardized recommendations for diagnosis and treatment of SSc.

Entities:  

Mesh:

Year:  2007        PMID: 17846731     DOI: 10.1007/s00105-007-1379-9

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  8 in total

1.  Unclassified or undifferentiated connective tissue disease.

Authors:  G S Alarcón
Journal:  Baillieres Best Pract Res Clin Rheumatol       Date:  2000-03       Impact factor: 4.098

2.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

Authors:  E C LeRoy; C Black; R Fleischmajer; S Jablonska; T Krieg; T A Medsger; N Rowell; F Wollheim
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

Review 3.  Scleroderma overlap syndromes.

Authors:  R M Bennett
Journal:  Rheum Dis Clin North Am       Date:  1990-02       Impact factor: 2.670

4.  Undifferentiated connective tissue syndromes.

Authors:  E C LeRoy; H R Maricq; M B Kahaleh
Journal:  Arthritis Rheum       Date:  1980-03

5.  Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963-1982.

Authors:  V D Steen; C V Oddis; C G Conte; J Janoski; G Z Casterline; T A Medsger
Journal:  Arthritis Rheum       Date:  1997-03

6.  Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients.

Authors:  H Poormoghim; M Lucas; N Fertig; T A Medsger
Journal:  Arthritis Rheum       Date:  2000-02

7.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

8.  Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.

Authors:  P Clements; P Lachenbruch; J Siebold; B White; S Weiner; R Martin; A Weinstein; M Weisman; M Mayes; D Collier
Journal:  J Rheumatol       Date:  1995-07       Impact factor: 4.666

  8 in total
  1 in total

Review 1.  Pharmacology and rationale for imatinib in the treatment of scleroderma.

Authors:  Pia Moinzadeh; Nicolas Hunzelmann; Thomas Krieg
Journal:  J Exp Pharmacol       Date:  2013-04-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.